select trial glp 1 Revising our earlier interpretation of

[9] [10] The combination of medications may have additive effects on hydration status that would not occur with GLP-1 therapy alone

Altogether, these challenges highlight that while significant progress has been made in RNA chemistry and nanoparticle delivery, realizing the full clinical potential of RNA therapeutics depends on coordinated advances in materials science, scalable and consistent manufacturing, and a deeper understanding of biological systems to develop safe, effective, and reproducible delivery platforms

It is involved in mitochondrial function, connective tissue enzymes, neurotransmitter synthesis, and antioxidant defenses

doi: 10.1038/srep14793 45 VelinDFavreLBernasconiEBachmannDPythoudCSaijiEet al